Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

10.40
+0.02000.19%
Post-market: 10.400.00000.00%18:59 EDT
Volume:1.21M
Turnover:12.60M
Market Cap:3.27B
PE:958.61
High:10.46
Open:10.33
Low:10.26
Close:10.38
52wk High:10.46
52wk Low:6.69
Shares:314.08M
Float Shares:168.50M
Volume Ratio:0.68
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0108
EPS(LYR):-0.3783
ROE:-881.26%
ROA:6.85%
PB:-29.13
PE(LYR):-27.49

Loading ...

May 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 08, 2025

Major Issues Report

Form 8-K - Current report
May 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 07, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 05, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 28, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2025

Major Issues Report

Form 8-K - Current report
Jan 15, 2025

Major Issues Report

Form 8-K - Current report
Jan 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 22, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]